FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966304850> ?p ?o ?g. }

• W1966304850 endingPage "2337" @default.
• W1966304850 startingPage "2331" @default.
• W1966304850 abstract "We addressed the effect of post-transplant lymphoproliferative disorder (PTLD) treatment with rituximab monotherapy or CHOP-based chemotherapy (± rituximab) after upfront immunosuppression reduction (IR) on renal graft function in a longitudinal analysis of 58 renal transplant recipients with PTLD and 610 renal transplant controls. Changes in the estimated glomerular filtration rate over time were calculated from a total of 6933 creatinine measurements over a period of > 1 year using a linear mixed model with random and fixed effects. Renal graft function significantly improved with treatment of PTLD, especially in the chemotherapy subgroup. Patients treated with IR+chemotherapy ± rituximab had a noninferior graft function compared with untreated controls suggesting that the negative impact of IR on the renal graft function can be fully compensated by the immunosuppressive effect of CHOP. The immunosuppressive effect of single agent rituximab may partially compensate the negative impact of IR on the graft function. Thus, it is possible to reduce immunosuppression when using chemotherapy to treat PTLD. We addressed the effect of post-transplant lymphoproliferative disorder (PTLD) treatment with rituximab monotherapy or CHOP-based chemotherapy (± rituximab) after upfront immunosuppression reduction (IR) on renal graft function in a longitudinal analysis of 58 renal transplant recipients with PTLD and 610 renal transplant controls. Changes in the estimated glomerular filtration rate over time were calculated from a total of 6933 creatinine measurements over a period of > 1 year using a linear mixed model with random and fixed effects. Renal graft function significantly improved with treatment of PTLD, especially in the chemotherapy subgroup. Patients treated with IR+chemotherapy ± rituximab had a noninferior graft function compared with untreated controls suggesting that the negative impact of IR on the renal graft function can be fully compensated by the immunosuppressive effect of CHOP. The immunosuppressive effect of single agent rituximab may partially compensate the negative impact of IR on the graft function. Thus, it is possible to reduce immunosuppression when using chemotherapy to treat PTLD." @default.
• W1966304850 created "2016-06-24" @default.
• W1966304850 creator A5004915176 @default.
• W1966304850 creator A5014219629 @default.
• W1966304850 creator A5015917994 @default.
• W1966304850 creator A5037283048 @default.
• W1966304850 creator A5040437868 @default.
• W1966304850 creator A5044663397 @default.
• W1966304850 creator A5046049357 @default.
• W1966304850 creator A5050630680 @default.
• W1966304850 creator A5056730093 @default.
• W1966304850 creator A5060425510 @default.
• W1966304850 creator A5061694042 @default.
• W1966304850 creator A5066826766 @default.
• W1966304850 creator A5072802171 @default.
• W1966304850 creator A5077036757 @default.
• W1966304850 creator A5080134418 @default.
• W1966304850 creator A5085255418 @default.
• W1966304850 creator A5085406499 @default.
• W1966304850 date "2009-10-01" @default.
• W1966304850 modified "2023-10-13" @default.
• W1966304850 title "Treatment of PTLD with Rituximab and CHOP Reduces the Risk of Renal Graft Impairment after Reduction of Immunosuppression" @default.
• W1966304850 cites W1543833158 @default.
• W1966304850 cites W1901176265 @default.
• W1966304850 cites W1933649159 @default.
• W1966304850 cites W1968111008 @default.
• W1966304850 cites W1997558610 @default.
• W1966304850 cites W2013903721 @default.
• W1966304850 cites W2017023847 @default.
• W1966304850 cites W2024382442 @default.
• W1966304850 cites W2031101358 @default.
• W1966304850 cites W2048288179 @default.
• W1966304850 cites W2066846899 @default.
• W1966304850 cites W2072616676 @default.
• W1966304850 cites W2074712439 @default.
• W1966304850 cites W2075396034 @default.
• W1966304850 cites W2128732540 @default.
• W1966304850 cites W2135255328 @default.
• W1966304850 cites W2135455909 @default.
• W1966304850 cites W2137858837 @default.
• W1966304850 cites W2151139118 @default.
• W1966304850 cites W2168772082 @default.
• W1966304850 cites W2170104954 @default.
• W1966304850 cites W2585109591 @default.
• W1966304850 cites W4290120021 @default.
• W1966304850 doi "https://doi.org/10.1111/j.1600-6143.2009.02772.x" @default.
• W1966304850 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19663889" @default.
• W1966304850 hasPublicationYear "2009" @default.
• W1966304850 type Work @default.
• W1966304850 sameAs 1966304850 @default.
• W1966304850 citedByCount "43" @default.
• W1966304850 countsByYear W19663048502012 @default.
• W1966304850 countsByYear W19663048502013 @default.
• W1966304850 countsByYear W19663048502014 @default.
• W1966304850 countsByYear W19663048502015 @default.
• W1966304850 countsByYear W19663048502016 @default.
• W1966304850 countsByYear W19663048502017 @default.
• W1966304850 countsByYear W19663048502018 @default.
• W1966304850 countsByYear W19663048502021 @default.
• W1966304850 crossrefType "journal-article" @default.
• W1966304850 hasAuthorship W1966304850A5004915176 @default.
• W1966304850 hasAuthorship W1966304850A5014219629 @default.
• W1966304850 hasAuthorship W1966304850A5015917994 @default.
• W1966304850 hasAuthorship W1966304850A5037283048 @default.
• W1966304850 hasAuthorship W1966304850A5040437868 @default.
• W1966304850 hasAuthorship W1966304850A5044663397 @default.
• W1966304850 hasAuthorship W1966304850A5046049357 @default.
• W1966304850 hasAuthorship W1966304850A5050630680 @default.
• W1966304850 hasAuthorship W1966304850A5056730093 @default.
• W1966304850 hasAuthorship W1966304850A5060425510 @default.
• W1966304850 hasAuthorship W1966304850A5061694042 @default.
• W1966304850 hasAuthorship W1966304850A5066826766 @default.
• W1966304850 hasAuthorship W1966304850A5072802171 @default.
• W1966304850 hasAuthorship W1966304850A5077036757 @default.
• W1966304850 hasAuthorship W1966304850A5080134418 @default.
• W1966304850 hasAuthorship W1966304850A5085255418 @default.
• W1966304850 hasAuthorship W1966304850A5085406499 @default.
• W1966304850 hasBestOaLocation W19663048501 @default.
• W1966304850 hasConcept C126322002 @default.
• W1966304850 hasConcept C126894567 @default.
• W1966304850 hasConcept C141071460 @default.
• W1966304850 hasConcept C143998085 @default.
• W1966304850 hasConcept C159641895 @default.
• W1966304850 hasConcept C2776694085 @default.
• W1966304850 hasConcept C2779338263 @default.
• W1966304850 hasConcept C2780252810 @default.
• W1966304850 hasConcept C2780306776 @default.
• W1966304850 hasConcept C2780653079 @default.
• W1966304850 hasConcept C2781146716 @default.
• W1966304850 hasConcept C2911091166 @default.
• W1966304850 hasConcept C71924100 @default.
• W1966304850 hasConcept C90924648 @default.
• W1966304850 hasConceptScore W1966304850C126322002 @default.
• W1966304850 hasConceptScore W1966304850C126894567 @default.
• W1966304850 hasConceptScore W1966304850C141071460 @default.
• W1966304850 hasConceptScore W1966304850C143998085 @default.
• W1966304850 hasConceptScore W1966304850C159641895 @default.
• W1966304850 hasConceptScore W1966304850C2776694085 @default.

• next